Linea Natalie Toksvang

11PUBLICATIONS
36CO-AUTHORS
Solid tumoursGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Gene and molecular therapyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2026
A Phase Ib/II Study of Atezolizumab in Combination with Thiopurine Therapy in Patients with Metastatic Solid Tumors and Intermediate Tumor Mutational Burden.

|Dec 09, 2025
Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia.

Theis Mikkelsen, Marianne Helenius, Mirella Ampatzidou

|Nov 22, 2025
LC-MS/MS quantification of 6-methylthio-2'-deoxyguanosine and 6-thio-2'-deoxyguanosine in genomic DNA with enzymatically synthesized isotope-labelled internal standards.

Malene Johanne Petersen, Allan Weimann, Maria Thastrup

|Jul 16, 2025
DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

Mathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen

|Jun 02, 2022
Maintenance therapy for acute lymphoblastic leukemia: basic science and clinical translations.

Linea N Toksvang, Shawn H R Lee, Jun J Yang

|May 03, 2022
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.

Linea Natalie Toksvang, Bodil Als-Nielsen, Christopher Bacon

Pageof 2

Frequent Collaborators

9 joint publications

Kjeld Schmiegelow

4 joint publications

Jacob Nersting

2 joint publications

Jonas Abrahamsson

2 joint publications

Maria Thastrup